Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 2.83M
2: EX-10.3 Material Contract HTML 41K
3: EX-10.4 Material Contract HTML 38K
4: EX-21 Subsidiaries List HTML 51K
5: EX-23.1 Consent of Expert or Counsel HTML 39K
9: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 58K Awarded Compensation
6: EX-31.1 Certification -- §302 - SOA'02 HTML 43K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 43K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 42K
15: R1 Document and Entity Information Document HTML 105K
16: R2 Audit Information HTML 44K
17: R3 Consolidated Balance Sheets HTML 169K
18: R4 Consolidated Statements of Income HTML 117K
19: R5 Statement of Comprehensive Income (Statement) HTML 66K
20: R6 Consolidated Statements of Stockholders Equity HTML 100K
21: R7 Consolidated Statements of Cash Flows HTML 181K
22: R8 Consolidated Balance Sheets (Parenthetical) HTML 61K
23: R9 Statement of Comprehensive Income (Paranthetical) HTML 47K
24: R10 General and Summary of Significant Accounting HTML 233K
Policies
25: R11 Acquisitions (Notes) HTML 75K
26: R12 Restructuring, Strategic Transaction and HTML 69K
Integration (Notes)
27: R13 Revenue (Notes) HTML 106K
28: R14 Leases (Notes) HTML 98K
29: R15 Share Based Award Share awards (Notes) HTML 143K
30: R16 Derivatives and Hedging Activities (Notes) HTML 106K
31: R17 Fair Value Measurement (Notes) HTML 143K
32: R18 Prepaids and Other Current Assets (Notes) HTML 64K
33: R19 Accrued Liabilities an Other Long-term Liabilities HTML 81K
34: R20 Debt HTML 97K
35: R21 Income Taxes HTML 169K
36: R22 Geographic Information and Significant Customers HTML 58K
Geographic Information and Significant Customers
(Notes)
37: R23 Stockholders' Equity HTML 79K
38: R24 Commitments and Contingencies HTML 48K
39: R25 Collaborative and Other Arrangements (Notes) HTML 44K
40: R26 Transfers and Servicing HTML 49K
41: R27 SEC Schedule, Article 12-09, Valuation and HTML 90K
Qualifying Accounts
42: R28 Pay vs Performance Disclosure HTML 51K
43: R29 Insider Trading Arrangements HTML 49K
44: R30 General and Summary of Significant Accounting HTML 124K
Policies (Policies)
45: R31 General and Summary of Significant Accounting HTML 214K
Policies (Tables)
46: R32 Business Combination and Asset Acquisition HTML 68K
(Tables)
47: R33 Restructuring, Strategic Transaction and HTML 65K
Integration Schedule of Restructuring and Related
Costs (Tables)
48: R34 Revenue (Tables) HTML 99K
49: R35 Leases (Tables) HTML 102K
50: R36 Share Based Award (Tables) HTML 131K
51: R37 Derivatives and Hedging Activities (Tables) HTML 99K
52: R38 Fair Value Measurement (Tables) HTML 127K
53: R39 Prepaids and Other Current Assets (Tables) HTML 66K
54: R40 Accrued Liabilities an Other Long-term Liabilities HTML 82K
(Tables)
55: R41 Debt (Tables) HTML 86K
56: R42 Income Taxes Income tax disclosure (Tables) HTML 170K
57: R43 Geographic Information and Significant Customers HTML 58K
Geographic Information (Tables)
58: R44 Stockholders' Equity (Tables) HTML 72K
59: R45 General and Summary of Significant Accounting HTML 41K
Policies Basis of Presentation (Details)
60: R46 General and Summary of Significant Accounting HTML 47K
Policies Inventory (Details)
61: R47 General and Summary of Significant Accounting HTML 63K
Policies Property and Equipment #1 (Details)
62: R48 General and Summary of Significant Accounting HTML 61K
Policies Property and Equipment #2 (Details)
63: R49 General and Summary of Significant Accounting HTML 41K
Policies Property and Equipment #3 (Details)
64: R50 General and Summary of Significant Accounting HTML 54K
Policies Goodwill (Details)
65: R51 General and Summary of Significant Accounting HTML 77K
Policies Intangible Assets #1 (Details)
66: R52 General and Summary of Significant Accounting HTML 41K
Policies Intangible Assets #2 (Details)
67: R53 General and Summary of Significant Accounting HTML 55K
Policies Future Estimated Amortization Expense
(Details)
68: R54 General and Summary of Significant Accounting HTML 72K
Policies Investments (Details)
69: R55 General and Summary of Significant Accounting HTML 50K
Policies Investments-Equity Method (Details)
70: R56 General and Summary of Significant Accounting HTML 42K
Policies Income Taxes
71: R57 General and Summary of Significant Accounting HTML 42K
Policies Foreign Currency (Details)
72: R58 General and Summary of Significant Accounting HTML 40K
Policies Post-retirement and Post-employment
Benefits (Details)
73: R59 General and Summary of Significant Accounting HTML 46K
Policies Interest (Expense) Income, net (Details)
74: R60 General and Summary of Significant Accounting HTML 55K
Policies Other (Expense) Income, Net (Details)
75: R61 General and Summary of Significant Accounting HTML 73K
Policies Net Income Per Share (Details)
76: R62 General and Summary of Significant Accounting HTML 56K
Policies New Accounting Pronouncements (Details)
77: R63 Acquisitions Text (Details) HTML 62K
78: R64 Acquisitions Smiths Medical 2020 Limited Table HTML 95K
(Details)
79: R65 Acquisitions Smiths Medical 2020 Limited HTML 55K
Intangible (Details)
80: R66 Acquisitions Smiths Medical Pro Forma (Details) HTML 72K
81: R67 Acquisitions Foreign Infusion Systems Supplier HTML 53K
(Details)
82: R68 Restructuring, Strategic Transaction and HTML 45K
Integration (Details 1)
83: R69 Restructuring, Strategic Transaction and HTML 64K
Integration (Details 2)
84: R70 Restructuring, Strategic Transaction and HTML 40K
Integration Strategic Transaction and Integration
Expenses (Details)
85: R71 Revenue Disaggregation of Revenue - Product Line HTML 58K
(Details)
86: R72 Revenue Disaggregation of Revenue by Geography HTML 62K
(Details)
87: R73 Revenue Contract Liabilities (Details) HTML 57K
88: R74 Revenue Contract Liabilities Text (Details) HTML 40K
89: R75 Revenue Remaining Performance Obligation HTML 55K
Recognition Timing (Details)
90: R76 Leases (Details) HTML 46K
91: R77 Leases Lease Cost (Details) HTML 50K
92: R78 Leases Supplemental Cash Flow Lease Information HTML 50K
(Details)
93: R79 Leases Supplemental Balance Sheet Lease HTML 56K
information (Details)
94: R80 Finance Leases Supplemental Balance Sheet HTML 58K
Information (Details)
95: R81 Leases Lease Maturity (Details) HTML 58K
96: R82 Leases Finance Lease Maturity (Details) HTML 58K
97: R83 Share Based Award Stock Based Compensation HTML 49K
(Details)
98: R84 Share Based Award Stock Option Plans (Details) HTML 51K
99: R85 Share Based Award Stock Options Granted and HTML 66K
Valuation (Details)
100: R86 Share Based Award Stock Option Activity (Details) HTML 92K
101: R87 Share Based Award Share Award data (Details) HTML 40K
102: R88 Share Based Award Options exercised data (Details) HTML 45K
103: R89 Share Based Award RSU and PRSU (Details) HTML 67K
104: R90 Share Based Award RSU and PRSU Roll forward HTML 78K
(Details)
105: R91 Share Based Award ESPP Narrative (Details) HTML 41K
106: R92 Derivatives and Hedging Activities Foreign HTML 67K
Exchange Forward Contracts(Details)
107: R93 Derivatives and Hedging Activities Interest Rate HTML 65K
Contracts(Details)
108: R94 Derivatives and Hedging Activities Derivative HTML 86K
Balance Sheet Location (Details)
109: R95 Derivatives and Hedging Activities Derivative HTML 63K
Instruments and Hedging Activities - Amounts
Affecting Consolidated Statements of Income
(Details)
110: R96 Derivatives and Hedging Activities Derivative HTML 49K
Instruments and Hedging Activities - Cash Flow
Hedge Activity Included in Accumulated Other
Comprehensive Income (Loss) (Details)
111: R97 Fair Value Measurement Smiths Medical(Details) HTML 47K
112: R98 Fair Value Measurement Text Pursuit (Details) HTML 56K
113: R99 Fair Value Measurement Roll Forward (Details) HTML 66K
114: R100 Fair Value Measurement Smiths Medical Simulation HTML 46K
Inputs (Details)
115: R101 Fair Value Measurement Fair Value Measurements, HTML 120K
Recurring Basis (Details)
116: R102 Prepaid Expenses and Other Current Assets HTML 62K
(Details)
117: R103 Prepaids and Other Noncurrent Assets (Details) HTML 57K
118: R104 Accrued Liabilities (Details) HTML 86K
119: R105 Other Liabilities (Details) HTML 58K
120: R106 2022 Credit Facility Text (Details) HTML 92K
121: R107 2017 Credit Facility (Details) HTML 46K
122: R108 Applicable Margin Based on Leverage Ratio Term HTML 62K
Loan A(Details)
123: R109 Applicable Margin Based on Leverage Ratio Term HTML 47K
Loan B (Details)
124: R110 Debt (Details) HTML 68K
125: R111 Debt Maturity (Details) HTML 58K
126: R112 Debt Interest Expense (Details) HTML 50K
127: R113 Principal Payments (Details) HTML 40K
128: R114 Income Taxes Income (Loss) from Continuing HTML 46K
Operations (Details)
129: R115 Income Taxes Tax Provision (Details) HTML 65K
130: R116 Income Taxes Change in taxes payable (Details) HTML 40K
131: R117 Income Taxes Effective tax rate (Details) HTML 100K
132: R118 Income Taxes Deferred income tax assets HTML 78K
(Liabilities) (Details)
133: R119 Income Taxes Operating Loss Carryforwards HTML 46K
(Details)
134: R120 Income Taxes Tax Carryforwards (Details) HTML 45K
135: R121 Income Taxes Tax Holiday (Details) HTML 43K
136: R122 Income Taxes Undistributed foreign earnings HTML 41K
(Details)
137: R123 Income Taxes Unrecognized tax benefits (Details) HTML 55K
138: R124 Income Taxes Unrecognized tax benefits Text HTML 55K
(Details)
139: R125 Geographic Information and Significant Customers HTML 71K
Long Lived Assets by Geographic Location (Details)
140: R126 Stockholders' Equity (Details) HTML 48K
141: R127 Stockholders' Equity Accumulated Other HTML 69K
Comprehensive Income (Loss) (Details)
142: R128 Commitments and Contingencies Contingencies HTML 71K
(Details)
143: R129 Collaborative and Other Arrangements (Details) HTML 41K
144: R130 Transfers and Servicing (Details) HTML 50K
145: R131 SEC Schedule, Article 12-09, Valuation and HTML 68K
Qualifying Accounts (Details)
147: XML IDEA XML File -- Filing Summary XML 279K
150: XML XBRL Instance -- icui-20231231_htm XML 3.68M
146: EXCEL IDEA Workbook of Financial Report Info XLSX 281K
11: EX-101.CAL XBRL Calculations -- icui-20231231_cal XML 208K
12: EX-101.DEF XBRL Definitions -- icui-20231231_def XML 1.25M
13: EX-101.LAB XBRL Labels -- icui-20231231_lab XML 3.16M
14: EX-101.PRE XBRL Presentations -- icui-20231231_pre XML 1.90M
10: EX-101.SCH XBRL Schema -- icui-20231231 XSD 332K
148: JSON XBRL Instance as JSON Data -- MetaLinks 820± 1.23M
149: ZIP XBRL Zipped Folder -- 0000883984-24-000005-xbrl Zip 794K
‘EX-97.1’ — Clawback Policy re: Recovery of Erroneously Awarded Compensation
“Committee” means the committee of the Board responsible for executive compensation
decisions comprised solely of independent directors (as determined under the Applicable Rules),
or in the absence of such a committee, a majority of the independent directors
serving on the Board.
“Erroneously Awarded Compensation” means the amount of Incentive-Based
Compensation received by a current or former Officer that exceeds the amount of Incentive-Based
Compensation that would have been received by such current or former Officer based on a restated
Financial Reporting Measure, as determined on a pre-tax basis in accordance with the Applicable
Rules.
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
“Financial
Reporting Measure” means any measure determined and presented in
accordance with the accounting principles used in preparing the Company’s financial statements,
and any measures derived wholly or in part from such measures, including GAAP, IFRS and non-GAAP/IFRS financial measures, as well as stock or share price and total equityholder return.
“GAAP” means United States generally accepted accounting principles.
“IFRS” means international financial reporting standards as adopted by the International
Accounting
Standards Board.
“Impracticable” means (a) the direct costs paid to third parties to assist in enforcing
recovery would exceed the Erroneously Awarded Compensation; provided that the Company has
(i) made reasonable attempts to recover the Erroneously Awarded Compensation, (ii) documented
such attempt(s), and (iii) provided such documentation to the relevant listing exchange or
association, (b) to the extent permitted by the Applicable Rules, the recovery would violate the
Company’s home country laws pursuant to an opinion of home country counsel; provided that the
3
Company has (i) obtained an opinion of home country counsel, acceptable to the relevant listing
exchange or association, that recovery would result in such violation, and (ii) provided such
opinion to the relevant listing exchange or association, or (c) recovery would likely cause an
otherwise tax-qualified retirement plan, under which benefits are broadly available to employees
of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and
the
regulations thereunder.
“Incentive-Based Compensation” means, with respect to a Restatement, any
compensation that is granted, earned, or vested based wholly or in part upon the attainment of one
or more Financial Reporting Measures and received by a person: (a) after beginning service as an
Officer; (b) who served as an Officer at any time during the performance period for that
compensation; (c) while the Company has a class of securities listed on a national securities
exchange or association; and (d) during the applicable Three-Year Period.
“Officer”
means each person who serves as an executive officer of the Company, as defined
in Rule 10D-1(d) under the Exchange Act.
“Restatement” means an accounting restatement to correct the Company’s material
noncompliance with any financial reporting requirement under securities laws, including
restatements that correct an error in previously issued financial statements (a) that is material to
the previously issued financial statements or (b) that would result in a material misstatement if the
error
were corrected in the current period or left uncorrected in the current period.
“Three-Year Period” means, with respect to a Restatement, the three completed fiscal years
immediately preceding the date that the Board, a committee of the Board, or the officer or officers
of the Company authorized to take such action if Board action is not required, concludes, or
reasonably should have concluded, that the Company is required to prepare such Restatement, or,
if earlier, the date on which a court, regulator
or other legally authorized body directs the Company
to prepare such Restatement. The “Three-Year Period” also includes any transition period (that
results from a change in the Company’s fiscal year) within or immediately following the three
completed fiscal years identified in the preceding sentence. However, a transition period between
the last day of the Company’s previous fiscal year end and the first day of its new fiscal year that
comprises a period of nine to 12 months shall be deemed a
completed fiscal year.
4
Dates Referenced Herein and Documents Incorporated by Reference
